AVDL

Avadel Pharmaceuticals

71 hedge funds and large institutions have $332M invested in Avadel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $342M → $332M (-$10.3M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.45M
Puts
$611K
Net Calls
Net Calls Change

Top Buyers

1 +$6.61M
2 +$5.72M
3 +$4.4M
4
TI
Turner Investments
Pennsylvania
+$2.7M
5
Morgan Stanley
Morgan Stanley
New York
+$2.18M

Top Sellers

1 -$9.45M
2 -$3.75M
3 -$2.72M
4
Millennium Management
Millennium Management
New York
-$2.2M
5
Jennison Associates
Jennison Associates
New York
-$1.54M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$75.2M
2
$71.6M
3
$18.3M
4
$14.8M
5
$12.7M
6
$10.5M
7
$10.2M
8
$9.97M
9
$9.08M
10
$8.73M
11
$8.04M
12
$7.16M
13
$6.77M
14
$6.7M
15
$6.61M
16
$6.31M
17
$5.72M
18
$5.18M
19
$4.73M
20
$4.29M
21
$3.36M
22
$2.97M
23
$2.01M
24
$1.86M
25
$1.73M